Bristol-Myers Squibb's News

Search by Type

Report DataBase News

Search by Company

Code Company name

Category

Home>Bristol-Myers Squibb's

Remember Me Next Time

Bristol-Myers Squibb's

Bristol-Myers Squibb Close to the 50 Day 2011-09-14
Bristol-Myers Squibb to Present at Bank of America Merrill Lynch Health Care Con2011-09-14
Trading Idea - Is Bristol-Myers Squibb close to Resistance? 2011-09-08
Bristol-Myers Squibb to Present at the Morgan Stanley Global Healthcare Conferen2011-09-08
5 Healthcare Stocks Investors are Buying This Morning2011-09-02
New Data from Bristol-Myers Squibb on NULOJIX(R) (belatacept) to be Presented at2011-09-02
Bristol-Myers Squibb Breaking Out? 2011-09-02
Bristol-Myers Squibb Close to Resistance 2011-09-01
7 High-Yield Large-Cap Pharmas: Recent Performance And Yield Review 2011-09-01
U.S. Infant-Formula Makers Expand In China2011-08-31
Hearty Profits: Companies Racing to Develop the Next Big Cholesterol Drug2011-08-31
Ben Graham's Assistant's 19 Bullish Stock Picks2011-08-31
5 Dividend-Payers To Weather Economic Storms2011-08-31
Healthcare Stocks Investors Sold August 30th2011-08-31
Stocks to watch Monday: Dresser-Rand, insurers2011-08-30
Wall Street Breakfast: Must-Know News 2011-08-30
Bristol-Myers Squibb - Shares Seeking Direction2011-08-30
Time To Take A Second Look At Big Pharma 2011-08-30
The Ratio That Beats The Market By 21.7%2011-08-30
ELIQUIS(R) (apixaban) was Superior to Warfarin for the Reduction of Stroke or Sy2011-08-29
Jim Cramer's Favorite 15 Stocks2011-08-29
Is Bristol-Myers Squibb a Buffett Stock?2011-08-26
Bristol-Myers Squibb And Pfizer Announce Data Presentations For Apixaban At Euro2011-08-24
Global Large-Cap Value Investing: An Interview With Jerrold K. Senser Of Institu2011-08-24
Bristol-Myers Squibb's Yervoy released in UK2011-08-23
Data may prove Bristol, Pfizer drug a winner2011-08-23
Drug Contract Manufacturer Ben Venue To Exit Business2011-08-22
Does Approval Cause Automatic Gains any Longer?2011-08-22
Trends and Analysis on Bristol-Myers Squibb Co.: PharmaVitae Profile 2011-08-19
Waiting for the market’s other shoe to drop2011-08-19
Insight Into Market Ahead - Equity Research on Gilead Sciences, Inc. and Bristol2011-08-19
Take Advantage of the Fire Sale in Healthcare 2011-08-19
Bristol Myers (BMY) Trading Near $28.12 Support Level2011-08-19
Large American Companies Amassing Cash, Hesitant toSpend2011-08-19

[ 1 ]